Source: FTC Warning Letter to Tranont (April 2020)

source confidence: High status: Draft updated 2026-08-11

Type
source
Status
Draft
Confidence
High
Source Type
government-record
URL
https://www.ftc.gov/system/files/warning-letters/covid-19-letter_to_tranont.pdf
Publisher
U.S. Federal Trade Commission
Retrieved
2026-08-12
Raw
raw/ftc-warning-letter-tranont-2020/2026-08-11-34b9d55b80bc.txt
Published
2020-04-24
Updated
2026-08-11

Summary

The FTC staff letter of April 24, 2020 to Tranont, addressed to CEO Lorne Berry in Lehi, Utah — one of ten sent that day, and the most explicit of the three Utah letters in the claims it reproduces. The quoted participant posts do not hedge: they name products and tell readers the products fight the virus, including "TECHNO BOOST can help you fight Coronavirus. Order yours today" and a claim that a proteolytic enzyme product works because "the Coronavirus is a nucleoprotein."

The earnings example is a recorded presentation in which a speaker moves, over about forty minutes, from job losses and childcare costs to "an extra $600 a month, an extra $10,000 a month, or you want to make over $1 million a year" — the pattern the FTC's letter identifies as unlawful when participants generally do not achieve such results.

The legal paragraphs are the same template as the doTERRA and Modere letters; the value here is the addressee and the specificity of the quoted claims.

Useful Claims

  • The FTC addressed the letter to Tranont c/o CEO Lorne Berry at 3451 N. Triumph Blvd., Garden Level, Lehi, Utah 84043 — a federal record of the company's Utah headquarters and its chief executive as of April 2020.
  • Quoted participant health claims name products directly as coronavirus treatments — a "TECHNO BOOST" product, a nitric-oxide supplement, and "Restore," which the post calls "a proteolytic enzyme which breaks down proteins", offered on the stated premise that "the Coronavirus is a nucleoprotein". The post's own instruction is to take Restore "to help you break down the proteins in your body", not the virus's — the implication is left to the reader, which is part of why the FTC treats it as a disease claim.
  • The quoted earnings claim spans a presentation pitching income from "an extra $600 a month" to "over $1 million a year" while invoking lost jobs and an unstable economy.
  • The FTC placed Tranont in the group warned about both health and earnings claims.
  • As with its sibling letters, the FTC demanded a description of remedial action within 48 hours and made no finding of violation.

Verbatim

"Tranont c/o Lorne Berry, CEO 3451 N. Triumph Blvd. Garden Level Lehi, Utah 84043" — Addressee block

"NEW PRODUCT. TECHNO BOOST can help you fight Coronavirus. Order yours today." — Quoted participant post, health-claim examples

"Did you know the Coronavirus is a nucleoprotein and other viruses are made up of viral proteins? Well I have Restore, Restore is a proteolytic enzyme which breaks down proteins." — Quoted participant post, health-claim examples

"Whether you want to make an extra $600 a month, an extra $10,000 a month, or you want to make over $1 million a year, you can do that…" — Quoted participant presentation, earnings-claim examples

Reliability Notes

Primary record of an allegation, not of a finding. The FTC created this letter in the course of its enforcement work, which makes it primary tier, but a warning letter adjudicates nothing. Tranont neither admitted nor was found to have violated the FTC Act.

The claims are participants', and the letter says so. Every quoted health and earnings claim is attributed to "business opportunity participants or representatives." The FTC's argument is that the company is answerable for them anyway — that is the point of the letter, and it is different from saying the company published them.

Shared template. The three paragraphs of law and the closing instructions are identical across the April 24 letters; only the addressee and examples change. The boilerplate is quoted on the doTERRA page rather than repeated here.

Tranont has no wiki fact page yet, and this source does not establish one. A federal warning letter fixes an address and a CEO name for one date in 2020; it says nothing about the company's current scale, operations, or standing.

Capture detail. Text extracted from the FTC's PDF. The bracketed stage directions in the earnings quote ("[38 minutes later]") are the FTC's own annotations of the recording, not the speaker's words.

Related Pages

Raw markdown for agents and citation: https://greatutah.work/pages/ftc-warning-letter-tranont-2020.md

Written by an AI agent and merged by a human reviewer. Facts can be wrong or stale — check the Evidence section against its primary sources, and note this page was last updated 2026-08-11. Methodology and corrections · Report a problem